Wednesday, September 21 |
6:00 PM |
Conference Registration |
|
8:00 PM |
Welcome Reception/Dinner |
|
Thursday, September 22 |
7:30 AM |
Breakfast |
|||
8:25 AM |
Welcome and Opening Remarks |
|||
|
||||
SESSION I |
Chronic tissue Injury and repair Chairs: Thomas Wynn and Stefan Wollin |
|||
8:30 AM |
1 |
Myeloid cell regulation of adult lung alveologenesis post-pneumonectomy Andrew Lechner and Jason Rock |
||
8:55 AM |
2 |
TBA Paul Noble |
||
9:20 AM |
3 |
Immunoregulation of liver fibrosis: novel pathways Sophie Lotersztajn |
||
9:45 AM |
4 |
Contribution of hepatic stellate cells to hepatic wound healing and carcinogenesis Robert Schwabe |
||
10:10 AM |
5 |
Novel pharmacological approaches for the treatment of Non-Alcoholic Steatohepatitis (NASH) James Trevaskis, Silvia Guionaud, Hani Jouihan, Michelle Beaton, Peter Ravn, Sarah Will, Michael Feigh, Sanne Skovgaard Veidal, Matthew Coghlan, Joseph Grimsby, Anish Konkar, Cristina Rondinone, and Lutz Jermutus |
||
10:35 AM |
6 |
Type 2 immunity protects against obesity-induced metabolic disease but exacerbates NAFLD collaboratively with TGF-β1 Kevin Hart, Thomas Fabre, Richard Gieseck, Lee Borthwick, Kevin Vannella, Robert Thompson, Sandra White, Genevieve Soucy, Marc Bilodeau, Thirumalai Ramalingam, Naglaa Shoukry, and Thomas Wynn |
||
10:50 AM |
7 |
Anti-LOXL2 treatment paves the way for macrophage-mediated collagen degradation in liver fibrosis Mordehay Klepfish, Milena Vugman, Chen Varol, and Irit Sagi |
||
11:05 AM |
Coffee Break/Poster Viewing |
|||
SESSION II |
Focus on liver regeneration and fibrosis Chairs: Ludovic Vallier and Lee A Borthwick |
|||
12:00 PM |
8 |
Targeting rebound inflammation to improve anti-fibrotic therapy Thiru Ramalingam, Richard (Trey) Gieseck, Tommy Acciani, Kevin Hart, Allen Cheever, Margaret Mentink-Kane, Kevin Vannella, and Thomas A Wynn |
||
12:25 PM |
9 |
Intravital imaging of liver regeneration and repair Neil Henderson |
||
12:50 PM |
10 |
Epigenetic control of wound healing and tissue fibrosis Derek Mann |
||
1:15 PM |
11 |
Hepatic stellate cells, hedgehog and hepatocyte reprogramming Ana Mae Diehl |
||
1:40 PM |
12 |
Interleukin-13 drives distinct cellular pathways directing regeneration and fibrosis Richard Gieseck, Thirumulai Ramalingam, Kevin Hart, Kevin Vannella, David Cantu, Wei-Yu Lu, Sofia Ferreira-Gonzalez, Stuart Forbes, Ludovic Vallier, and Thomas Wynn |
||
1:55 PM |
13 |
Sortilin deficiency attenuates ductular reaction and bile duct morphogenesis following cholestasis-induced liver injury Einav Hubel, Elise Lavoie, Roy Avraham, Sigal Fishman, Jonathan Dranoff, Oren Shibolet, and Isabel Zvibel |
||
2:10 PM |
Lunch and Informal Discussions |
|||
7:30 PM |
Dinner and Informal Discussions |
|||
Friday, September 23 |
7:30 AM |
Breakfast |
|||
SESSION III |
Progenitor cells and regeneration Chairs: Neil Henderson and Paola Romagnani |
|||
8:30 AM |
14 |
Human induced pluripotent stem cells to model inherited metabolic disorders Ludovic Vallier |
||
8:55 AM |
15 |
Liver regeneration from hepatic progenitor cells Stuart Forbes |
||
9:20 AM |
16 |
Generation of functional islets of langerhans from human exocrine pancreas Kevin Docherty |
||
9:45 AM |
17 |
Dissecting the molecular and cellular mechanisms responsible for tissue repair in inflammatory bowel disease Shiro Yui, Jordi Guiu, Pawel Schweiger, and Kim Jensen |
||
10:10 AM |
18 |
Regeneration of the biliary tree using primary extra-hepatic cholangiocyte organoids Fotios Sampaziotis, Richard Gieseck, Natalie Lie Berntsen, Miguel Cardoso de Brito, Steve Sawiak, María Gómez-Vázquez, Olivia Tysoe, Daniel Ortmann, Alessandro Bertero, Johannes Bargehr, Mariëlle Zonneveld, Loukia Yiangou, Negar Pirmadjid, Marianne Pedersen, Matthias Pawlowski, Nikitas Georgakopoulos, Edmund Godfrey, Sara Upponi, Casey Rimland, Ingrid Simonic, Susan Davies, Kim Jensen, William Gelson, Sanjay Sinha, Graeme Alexander, Nicholas Hannan, Espen Melum, Tom Wynn, Kourosh Saeb-Parsy, and Ludovic Vallier |
||
10:25 AM |
19 |
Type I, III collagen and elastin remodeling is elevated in the precision-cut lung slice model of IPF and can be restored back to vehicle levels using a PDE inhibitor Niels Hansen, Morten Karsdal, Sarah Brockbank, Simon Cruwys, Alan Young, Puneeta Nath, and Diana Leeming |
||
10:40 AM |
Coffee Break/Poster Viewing |
|||
SESSION IV |
Myofibroblasts and Biomarkers Chairs: Joseph Arron and Bryan Fuchs |
|||
11:40 AM |
20 |
Biomarkers of fibrosis progression; a route to shorter and smaller clinical trials Toby Maher |
||
12:00 PM |
21 |
Novel biomarkers and mechanisms of lung fibrosis Oliver Eickelberg |
||
12:25 PM |
22 |
Periplakin: a target for autoimmunity in lung fibrosis Bruno Crestani |
||
12:50 PM |
23 |
Myofibroblast mechanical memory Boris Hinz |
||
1:15 PM |
24 |
Alveolar regulation of TGFβ activation Gisli Jenkins |
||
1:40 PM |
25 |
Redox regulation of cardiomyocyte renewal Hesham Sadek |
||
2:05 PM |
Lunch and Informal Discussions |
|||
7:30 PM |
Dinner and Informal Discussions |
|||
Saturday, September 24 |
7:30 AM |
Breakfast |
||
SESSION V |
Therapeutic strategies Chairs: Stuart Forbes and Paul Noble |
||
8:30 AM |
26 |
Fingerprints of Fibrosis: Tracing pathogenic mechanisms in human tissue Carmel Nanthakumar, Adam Taylor, Lindsay Edwards, Susan Boyce, Richard Marshall, Andrew Fisher, Toby Maher, Gino Miele, Hannah Woodcock, Rachel Chambers, and Andy Blanchard |
|
8:55 AM |
27 |
Biomarker-Guided Therapeutic Strategies in IPF Joseph Arron |
|
9:20 AM |
28 |
Anti-inflammatory, anti-angiogenic, anti-fibrotic! The mode of action of nintedanib in fibrosing interstitial lung diseases. Lutz Wollin, Elizabeth Redente, David Riches, Joerg Distler, and Cara Williams |
|
9:45 AM |
29 |
Molecular pathways in kidney fibrosis Carol Moreno Quinn |
|
10:10 AM |
30 |
TBA Lynne Murray |
|
10:35 AM |
Coffee Break/Poster Viewing |
||
SESSION VI |
Immune mechanisms of repair and fibrosis Chairs: Sophie Lotersztajn and Jason Rock |
||
11:30 AM |
31 |
Myeloid cells in regeneration and fibrosis: dynamics, regulation and function Sabine Eming |
|
11:55 AM |
32 |
Translating scleroderma: pathogenic mechanisms and recent clinical trials Christopher Denton |
|
12:20 PM |
33 |
Purinergic Signaling in Fibrosis Bruce Cronstein and Gibran Sheikh |
|
12:45 PM |
34 |
From vasculopathy to immune activation and fibrosis - A Fli1 Odyssey Maria Trojanowska |
|
1:10 PM |
35 |
A retinoic acid dependent stroma-leukemia crosstalk promotes tissue remodeling and chronic lymphocytic leukemia progression Andrea Brendolan |
|
1:35 PM |
Lunch and Informal Discussions |
||
3:30 PM |
City Tour |
||
7:30 PM |
Dinner and Informal Discussions |
||
Sunday, September 25 |
7:30 AM |
Breakfast |
|||||
SESSION VII |
Fibrosis and regeneration across organ systems I Chairs: Lynne Murray and Sabine Eming |
|||||
8:30 AM |
36 |
Molecular magnetic resonance imaging of fibrosis in animal models Bryan Fuchs, Christian Farrar, Philip Waghorn, Lan Wei, Pauline Desogere, Bo Zhu, Michael Lanuti, Kenneth Tanabe, and Peter Caravan |
||||
8:55 AM |
37 |
The renal progenitor system in kidney homeostasis, injury and regeneration Paola Romagnani |
||||
9:20 AM |
38 |
Causes and effects of fibrosis in chronic muscle damage Marcela Low, Christine Eisner, Farshad Babaijhandagi, and Fabio Rossi |
||||
9:45 AM |
39 |
Autotaxin distorts lipid homeostasis promoting and interconnecting fibrosis and cancer Vassilis Aidinis |
||||
10:10 AM |
40 |
A Recombinant Antibody to Siglec-8 Inhibits Lung and Skin Fibrosis Rustom Falahati, Bradford Youngblood, John Leung, Alejandro Dorenbaum, Leonard Shultz, Dale Greiner, Michael Brehm, Christopher Bebbington, and Nenad Tomasevic |
||||
10:25 AM |
41 |
c-Rel is a master regulator of innate immunity and multi-organ fibrosis. Jack Leslie, Saimir Luli, Julie Worrell, Jonathan Scott, John Simpson, Neil Sheerin, Lee Borthwick, Derek Mann, and Fiona Oakley |
||||
10:40 AM |
42 |
The role of p21 activated kinase 1 (PAK1) in liver fibrosis Aoibheann Mullan, James Pritchett, Katherine Martin, Jessica Llewellyn, Varinder Athwal, Neil Hanley, and Karen Piper Hanley |
||||
10:55 AM |
Coffee Break/Poster Viewing |
|||||
SESSION VIII |
Fibrosis and regeneration across organ systems II Chairs: Derek Mann and Carol Moreno Quinn |
|||||
12:00 PM |
43 |
Immune Surveillance, Wound Repair and Fibrosis of the Salivary Gland Maria Kukuruzinska |
||||
12:25 PM |
44 |
Muscle stem cell regenerative decline in aging Laura García-Prat, Marta Martinez-Vicente, Marta Flandez, Sonia Alonso-Martín, Javier Rodríguez-Ubreva, Esteban Ballestar, Antonio Serrano, Marco Sandri, and Pura Muñoz-Cánoves |
||||
12:50 PM |
45 |
Building Better Bone: Biologic and Engineering Strategies for Managing Traumatic Bone Loss Robert Guldberg, Albert Cheng, Nick Willett, Mara Schenker, and Laxminarayanan Krishnan |
||||
1:15 PM |
46 |
Organ specific roles for FPR-1 in fibrosis Benjamin Millar, Jack Leslie, Alan Carruthers, John Ferguson, Matthew Sleeman, Saimir Luli, Rachel Howarth, Chris Fox, Lynne Murray, Donna Finch, Derek Mann, Andrew Fisher, and Lee A Borthwick |
||||
1:40 PM |
47 |
Yes Associated Protein 1 (YAP1) and Integrin α 11 β1 promote organ fibrosis James Pritchett, Katherine Martin, Jessica Llewellyn, Aoibheann Mullan, Emma Harvey, Sayyid Raza, Varinder Athwal, Neil Hanley, and Karen Piper Hanley |
||||
1:55 PM |
48 |
Rhamm deficiency impairs normal liver wound healing after acute hepatotoxin exposure Michele Pritchard and Jennifer McCracken |
||||
2:10 PM |
Closing Remarks |
|||||
2:15 PM |
Lunch and Informal Discussions |
|||||
8:00 PM |
Farewell Dinner |
|||||
Monday, September 26 |
7:30 AM |
Breakfast |
|||
10:30 AM |
Departure |
|||
POSTERS |
49 |
Protective role of the novel modulator spermidine in alcoholic liver injury, fibrosis, and liver regeneration Raj Lakshman, Ruchi Shah, and Karina Reyes-Gordillo |
50 |
Integrin alpha 11 as a novel therapeutic target in tissue fibrosis in multiple organs Ruchi Bansal, Shigeki Nakagawa, Scott Friedman, and Yujin Hoshida |
51 |
Development of injectable high molecular weight hyaluronic acid hydrogels for cartilage regeneration Shraddha Mondal |
52 |
Sortilin deficiency reduces ductular reaction, hepatocyte apoptosis and liver fibrosis in cholestatic-induced liver injury Einav Hubel, Ashish Saroha, Yael Pewzner-Jung, Anthony Futerman, Sigal Fishman, Jonathan Dranoff, Oren Shibolet, and Isabel Zvibel |
53 |
Intravital imaging of the hepatocyte regenerative niche following acetaminophen-induced liver injury Kylie Conroy, Alexandra Thompson, Stephen Greenhalgh, Martin Lee, John Iredale, Kenneth Simpson, Matthew Ford, Richard Mort, Alan Serrels, and Neil Henderson |
54 |
Dynamic fluid flow induces the osteogenic differentiation of human bone-derived mesenchymal stem cells Bumgeun Choi, Kang Yoon Kim, Tosol Yu, and Ki-Taek Lim |
55 |
Neutrophil extracellular traps components and mare endometrium fibrosis: are they related? Maria Rebordão, Ana Amaral, Karolina Lukasik, Anna Szostek, Antonio Galvão, Pedro Pinto-Bravo, Dariusz Skarzynski, and Graça Ferreira-Dias |
56 |
Role of Connective Tissue Growth Factor (CTGF/CCN2) in the fibrosis associated to denervated skeletal muscle and ALS disease progression Enrique Brandan, Daniela Rebolledo, David Gonzalez, Kenneth Lipson, Gail Walkinshaw, Waldo Cerpa, Felipe Court, and Brigitte Van Zundert |
57 |
Myeloid cell-produced p38a MAP kinase regulates the resolving phase of the tissue wound healing process Yacine Kharraz, Patrizia Pessina, Vanessa Ruiz-Bonilla, Mercè Jardi, and Pura Muñoz-Cánoves |
58 |
Prophylactic treatment with ALK5 inhibitor SB525334 significantly improves lung function tests and reduces accumulation of myofibroblasts in the mouse model of bleomycin induced pulmonary fibrosis Željka Anzulović, Maja Antolić, Snježana Čužić, Ines Glojnarić, and Boška Hrvačić |
59 |
A bleomycin in-vivo and an ex-vivo model combined with clinically validated serum extracellular matrix turnover markers of IPF may be used as an intelligent drug screening tool Diana Leeming, Sarah Brockbank, Niels Hansen, Morten Karsdal, Puneeta Nath, David Rider, Alan Young, and Simon Cruwys |
60 |
The assessment of clinically relevant extracellular matrix markers in a bleomycin-induced mouse model of lung fibrosis Alan Young, Puneeta Nath, Diana Leeming, Nils Ulrik Hansen, Morten Karsdal, Sarah Brockbank, David Rider, and Simon Cruwys |
61 |
Identification of differentially expressed long non-coding RNAs in human lung fibroblasts during idiopathic pulmonary fibrosis Marina Hadjicharalambous, Mark Lindsay, and Deborah Clarke |
62 |
Dissection of hedgehog and IL-13 pathways in liver fibrosis Thiago de Almeida Pereira, Lee Borthwick, Mariana Machado, Guanhua Xie, Paula Vidigal, Izabela Voieta, Vivian Rezende, Rafal Witek, José Lambertucci, Anna Diehl, and Thomas Wynn |
63 |
Disease relevant in vitro and in vivo models for lung fibrosis Jeroen DeGroot, Alan Young, Mary McElroy, Krista Ouwehand, and Loubna Chadli |
64 |
Progenitor cells in the human extrahepatic biliary tree and gallbladder Casey Rimland, Fotios Sampaziotis, Nikitas Georgakopoulos, Nicholas Hannan, Kourosh Saeb-Parsy, Thomas Wynn, and Ludovic Vallier |
65 |
The role of mast cells in thymic recovery after involution Valeriia Guselnikova |
66 |
New treatment option for children with encephalopathy Marcin Majka, Olga Milczarek, Bogna Badyra, and Stanislaw Kwiatkowski |
67 |
A novel biomarker of collagen type VII degradation is elevated in serum of patients with chronic obstructive pulmonary disease Jannie Sand, Patricia Lamy, Morten Karsdal, and Diana Leeming |
68 |
Versican degradation is associated with acute exacerbations of idiopathic interstitial pneumonia Jannie Sand, Yoshinori Tannino, T Nikaido, K Misa, Y Sato, R Togawa, X Wang, Diana Leeming, and M Munakata |
69 |
Objective quantitative evaluation of anti-fibrotic agents in animal models Kenneth Zhang, Li Chen, Bertha Xue, Chen Hu, Laurent Gole, and Chuan-Chu Chou |
70 |
Wnt-β catenin, a molecular mechanism of the anal sphincter injury induced fibrosis and sphincter dysfunction Ravinder Mittal and M. Raj Rajasekaran |
71 |
c-Rel is a critical regulator of epithelial cell fate during renal fibrosis Saimir Luli, Julie Worrell, Neil Sheerin, Lee Borthwick, Derek Mann, and Fiona Oakley |
72 |
Myf5+ stem cells of ventral dermis are dedifferentiated Schwann cells Haizea Iribar, Araika Gutierrez-Rivera, Virginia Perez-Lopez, and ander Izeta |
73 |
TGFβ-induced mitochondrial stress in lung fibroblasts and evidence to support extracellular mitochondrial DNA as a predictor of disease severity in IPF patients Glenda Trujillo, Changwan Ryu, Wajahat Mehal, Yonglin Chen, Huanxing Sun, Jose Herazo-Maya, Naftali Kaminski, Daniel Bogenhagen, and Erica Herzog |
74 |
Idiopathic pulmonary fibrosis fibroblasts in culture as a model system to generate extracellular matrix responses Breda Twomey and Tim Johnson |
75 |
AP-1/Fra-2 activation in macrophages is necessary for lung fibrosis development Alvaro Ucero, Latifa Bakiri, Masakatsu Suzuki, and Erwin Wagner |
|